Pharmabiz

Hutchmed begins phase III stage of the ongoing trial of the combination of surufatinib and camrelizumab to treat naïve pancreatic ductal adenocarcinoma

Hong Kong, Shanghai Tuesday, January 6, 2026, 13:00 Hrs [IST] ...
Pharmabiz

UK MHRA approves zapomeran mRNA Covid-19 vaccine for immunisation of individuals aged 18 years of age and older

The Medicines and Healthcare products Regulatory Agency (MHRA) has on 2nd January, 2026, approved zapomeran (Kostaive) mRNA Covid-19 vaccine, for the immunisation of individuals aged 18 years of age ...
Pharmabiz

China NMPA approves GSK’s Nucala to treat adults with chronic obstructive pulmonary disease

GSK plc announced that China’s National Medical Products Administration (NMPA) has approved Nucala (mepolizumab) as add-on maintenance treatment of adult patients with inadequately controlled COPD ...
Pharmabiz

AIOCD urges PM to shut down illegal e-pharmacies amid rising antibiotic resistance

AIOCD urges PM to shut down illegal e-pharmacies amid rising antibiotic resistance: Peethaambaran Kunnathoor, Chennai Tuesday ...
Pharmabiz

Healthcare providers call for adoption of ‘CIBIL-like’ framework for insurers

The West UP Chapter of the Association of Healthcare Providers India (AHPI) has called for the establishment of a ‘CIBIL-like’ rating framework for insurers and Third Party Administrators (TPAs) to ...
Pharmabiz

Oregon Health & Science University researchers find breast cancer drug boosts leukaemia treatment

A research team at Oregon Health & Science University (OHSU) has discovered a promising new drug combination that may help people with acute myeloid leukaemia overcome resistance to one of the most ...
Pharmabiz

CDSCO brings in guidelines and SOPs on compounding of offences

CDSCO brings in guidelines and SOPs on compounding of offences: Gireesh Babu, New Delhi Tuesday, January 6, 2026, 08:00 Hrs ...
Pharmabiz

US FDA accepts for priority review for Sanofi’s sBLA for Tzield for young children with stage 2 type 1 diabetes

US FDA accepts for priority review for Sanofi’s sBLA for Tzield for young children with stage 2 type 1 diabetes: Paris Tuesday, January 6, 2026, 12:00 Hrs [IST] The US Food and ...
Pharmabiz

Insilico Medicine announces US$ 888 million multi-year collaboration with Servier for drug discovery and development in oncology

Insilico Medicine announces US$ 888 million multi-year collaboration with Servier for drug discovery and development in oncology: Cambridge, Massachusetts Tuesday, January 6, 2026 ...
Pharmabiz

Indian pharma eyes promising prospects with needle-free drug delivery transforming patient safety & comfort

Indian pharma eyes promising prospects with needle-free drug delivery transforming patient safety & comfort: Nandita Vijayasimha, Bengaluru Tuesday, January 6, 2026, 09:00 Hrs [IS ...
Pharmabiz

UP govt to discuss Lalitpur bulk drugs park with pharma companies in Telangana on Jan 6

UP govt to discuss Lalitpur bulk drugs park with pharma companies in Telangana on Jan 6: Shardul Nautiyal, Mumbai Tuesday, January 6, 2026, 08:00 Hrs [IST] To boost self-reliance ...
Pharmabiz

IP-2026 introduces 3,340 monographs with blood component, excipient standards to boost patient safety

IP-2026 introduces 3,340 monographs with blood component, excipient standards to boost patient safety: Shardul Nautiyal, Mumbai Tuesday, January 6, 2026, 08:00 Hrs [IST] In a sign ...